Application of Tablet in Tablet technique to design and characterize immediate and modified release tablets of Timolol maleate
Hypertension is one of the major causes of mortality in the world. The non-selective -β-blocker which includes Timolol maleate (TM) is usually used in hypertension, at a given dose of 10–40 mg. The present research aims to design a tablet-in-tablet (TIT) formulation as a single-unit dosage form to a...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-02-01
|
| Series: | Heliyon |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024018516 |